RicardoSilvariño Uruguay

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Precise Phenotyping and Treatment SK01 HeatherReich Chairperson CanadaUniversity of Toronto, University Health Network SebastiánJaurretche Chairperson sebastianjaurretche@hotmail.comArgentinaSanatorio Parque SA Deciphering the IGAN Cell Atlas JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deGermanyHeidelberg University Complement-mediated Kidney Diseases in the Era of Complement Inhibitors MarinaVivarelli Speaker marina.vivarelli@opbg.netItalyLaboratory of Nephrology, Bambino Gesù Children's Hospital CART-T JonathanHogan Speaker jonathan.hogan@cabalettabio.comCabaletta Bio New Targets to Reduce the Burden of Rare Kidney Diseases LauraMariani Speaker lmariani@umich.eduUnited StatesUniversity of Michigan Q and A Hall C4
12:15 p.m. 1:15 p.m.	Onconephrology: Various Flavors of AKI CHAL02 JavierDe Arteaga Chairperson javierdearteaga@gmail.comArgentinaHospital Privado Universitario de Cordoba. Catholic University from Cordoba KarinaSoto Chairperson PortugalCentro Hospitalar de Setubal, EPE and CEDOC Universidade Nova de Lisboa SandraHerrmann Chairperson United StatesMayo Clinic AKI-related Cancer and Cancer Treatment-related TMA ClaraGarcía Carro Speaker SpainSan Carlos Clinical Hospital (Madrid, Spain) AKI Related to Cancer Immunotherapy: Can Biomarkers Help? SebastianLapman Speaker lapseba@yahoo.com.arArgentina Magnesium and AKI: Is There a Connection? From Bench to Bedside - What We Can Learn from Onconephrology JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland Q and A Hall E
2:45 p.m. 3:30 p.m.	What is ongoing in CKDu around the world? - CKDU interactive discussions (ISN i3C) SPOT-06 ErangaWijewickrama Spotlight Chairperson Sri LankaFaculty of Medicine, University of Colombo Jose VicenteSanchez Polo Spotlight Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) Magdalena Madero Spotlight Speaker MexicoChief of Nephrology, Instituto Nacional de Cardiologia Ignachi Chavez VivekanandJha Spotlight Speaker IndiaGeorge Institute for Global Health India NishanthaNanyakkara Spotlight Speaker nishantha4313@gmail.comSri Lanka Spotlight Stage 1 (exhibition hall)
3 p.m. 4 p.m.	Cardiorenal Syndrome: Updates in the Pathophysiology and State-of-the-Art Treatment IK01 FelipeInserra Chairperson felipe.inserra@gmail.comArgentina YelenaDrexler Chairperson yrd6@miami.eduUnited StatesUniversity of Miami Miller School of Medicine New Insights into the Mechanisms of Kidney Injury in the CRS WendyMccallum Speaker wmccallum@tuftsmedicalcenter.orgUnited States Novel Pharmacological Treatments of the CRS MarkSarnak Speaker msarnak@tuftsmedicalcenter.orgUnited StatesTufts Medical Center Device-related Treatment for CRS ClaudioRonco Speaker cronco@goldnet.itItalyInternational Renal Research Institute of Vicenza Q and A Hall D
4 p.m. 4:30 p.m.	Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis SPOT-07 BradRovin Spotlight Speaker United StatesThe Ohio State University UptalPatel Spotlight Speaker uptal@hibio.comUnited States Spotlight Stage 1 (exhibition hall)
5 p.m. 5:30 p.m.	Glomerular Disease Jeopardy SPOT-09 ArennJauhal Spotlight Chairperson Arenn.Jauhal@uhn.caCanada PaulaParnizari Croci Spotlight Chairperson Uruguay RichardLafayette Spotlight Chairperson United States Spotlight Stage 1 (exhibition hall)

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	ADPKD Updates LF04 CarlosDiaz Chairperson cdiaz@cemic.edu.arArgentinaSección Nefrología, Departamento de Medicina Interna, Instituto Universitario CEMIC. CristianKramer Chairperson cristiankramer@yahoo.esArgentinahosptial ramos mejìa Role of Genetic Testing in ADPKD PeterHarris Speaker United StatesMayo Clinic New Metabolic Pathways Driving PKD Progression AlessandraBoletta Speaker boletta.alessandra@hsr.itItalySan Raffaele Scientific Institute ADPKD Management Guidelines AlfredoWassermann Speaker awasser@gmail.comArgentinaFEPREVA The Future Landscape for ADPKD Treatment VicenteTorres Speaker United StatesMayo Clinic Q and A Hall C1
12:15 p.m. 1:15 p.m.	Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? SK04 MartaAdragna Chairperson marta.adragna@gmail.comArgentina MoumitaBarua Chairperson moumita.barua@uhn.caCanada Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? - All Patients Albertien M.Van Eerde Speaker a.vaneerde@umcutrecht.nlNetherlandsDepartment of Genetics, UMC Utrecht, The Netherlands Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? High-risk Populations Only HilaMilo Rasouly Speaker Hila.MiloRasouly@columbia.eduUnited StatesColumbia University Hall A
3 p.m. 4 p.m.	Treatment Goals for Severe Hyponatremia: A Debate on Current Guidelines Program LF1005 MitchellRosner Chairperson United StatesUniveristy of Virginia Health Overview of Hyponatremia Angela Yee-MoonWang Speaker SingaporeHong Kong/Singapore Pro: Current Guidelines are Appropriate HelbertRondon-Berrios Speaker rondonberriosh@upmc.eduUnited StatesUniversity of Pittsburgh School of Medicine Con: Current Guidelines are Too Conservative CarlosAyus Speaker carlosayus@yahoo.comUnited StatesUniversity of California Irvine Discussion Hall C3
4:30 p.m. 5:30 p.m.	Paraproteinemia and the Kidney CHAL05 CarolineLamarche Chairperson caroline.lamarche.1@umontreal.caCanadaUniversité de Montréal Gustavo CristianGreloni Chairperson gustavo.greloni@hospitalitaliano.org.arArgentina MGRS: Should All Forms Need Clonal Therapy? FrankBridoux Speaker f.bridoux@chu-poitiers.frFranceDepartment of Nephrology and French Reference Center for AL amyloidosis and MGRS, University Hospital, Poitiers, France Renal Amyloidosis: What Is New? Veronica Torres CostaSilva Speaker veronica.torres@hc.fm.usp.brBrazilSão Paulo State Cancer Institute - University of São Paulo Can We Perform a Transplant in Patients with Myeloma and Amyloidosis? SabineKaram Speaker United StatesUniversity of Minnesota Q and A Hall A
4:45 p.m. 5:30 p.m.	Implementing early CKD detection programs SPOT-19 AdeeraLevin Spotlight Speaker CanadaUniversity of British Columbia and Providence Health Care Jose VicenteSanchez Polo Spotlight Speaker visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) LauraSola Spotlight Speaker solalaura11@gmail.comUruguayDialysis Center, CASMU-IAMPP VivekanandJha Spotlight Speaker IndiaGeorge Institute for Global Health India Spotlight Stage 1 (exhibition hall)

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10:30 a.m.	Clinical Management of Glomerulonephritis (GN) SK06 Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comMexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ValeriaAlberton Chairperson vgalberton@gmail.comArgentinaHospital Fernandez/ Hospital El Cruce Updates on IgAN Management HernánTrimarchi Speaker ArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Membranous GN Classification and Management PierreRonco Speaker FranceHôpital Tenon MPGN Updates SanjeevSethi Speaker sethi.sanjeev@mayo.eduUnited StatesMayo Clinic Managing Vasculitis RobertaFenoglio Speaker roberta.fenoglio@unito.itItalyOspedale San Giovanni Bosco Q and A Hall A
11 a.m. 12:15 p.m.	Plenary Session 4: Insights into SGLT2 Inhibitors: A Story of Discovery (Ele Ferrannini, Italy) PL4 AlessiaFornoni Chairperson United StatesUniversity of Miami LizLightstone Chairperson United KingdomImperial College London MasaomiNangaku Chairperson JapanThe University of Tokyo Acceptance Speech: Bywaters Award MotokoYanagita Speaker JapanKyoto University Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture EleFerrannini Speaker eleferrannini@gmail.comItalyUniversity of Pisa ELP2 Graduation MasaomiNangaku Speaker JapanThe University of Tokyo Hall A
12:30 p.m. 1:30 p.m.	Complications and Nutritional Approaches to CKD: ISN-ISRNM Joint Session IK1003 Angela Yee-MoonWang Chairperson SingaporeHong Kong/Singapore ArmandoNegri Chairperson armando.negri@gmail.comArgentinaInstituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, Argentina CKD-induced Changes in Gut Microbiome in CKD DeniseMafra Speaker dmafra30@gmail.comBrazilFederal University Fluminense - UFF Personalized Nutrition Management of CKD Patients ConnieRhee Speaker crhee@mednet.ucla.eduUnited StatesUCLA The Gut-Kidney-Heart Axis in CKD: Beyond the Leaky Gut KeiichiSumida Speaker ksumida@uthsc.eduUnited StatesUniversity of Tennessee Health Science Center Q and A Hall C4